Exponent (EXPO) Asset Writedowns and Impairment (2010 - 2026)

Exponent has disclosed Asset Writedowns and Impairment across 17 years of filings, most recently posting $268000.0 for Q2 2026.

• Quarterly Asset Writedowns and Impairment rose 4.69% year-over-year to $268000.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $3.0 million (down 12.46% YoY) and the FY2026 annual result came in at $3.0 million, down 32.85% from the prior year.
• Asset Writedowns and Impairment declined to $268000.0 in Q2 2026, from $891000.0 in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $1.5 million in Q4 2025 and troughed at $256000.0 in Q2 2025.
• A 5-year average of $824235.3 and a median of $784000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment jumped 174.11% — and 2025, when it sank 79.98%.
• Tracing EXPO's Asset Writedowns and Impairment over 5 years: stood at $969000.0 in 2022, then jumped by 35.6% to $1.3 million in 2023, then sank by 40.56% to $781000.0 in 2024, then jumped by 93.47% to $1.5 million in 2025, then slumped by 82.26% to $268000.0 in 2026.
• Business Quant data shows EXPO's Asset Writedowns and Impairment at $268000.0 in Q2 2026, $891000.0 in Q1 2026, and $1.5 million in Q4 2025.